Your activity: 16 p.v.

Comparison of carboxyhemoglobin, methemoglobin, and sulfhemoglobin

Comparison of carboxyhemoglobin, methemoglobin, and sulfhemoglobin
  Carboxyhemoglobin Methemoglobin Sulfhemoglobin
Common causes
  • Inhaled CO gas from fires, gas-powered generators, kerosene heaters
  • Smoking
  • Ingested medication (dapsone, antimalarials)
  • Local anesthetic
  • Nitrates or nitrites
  • Ingested medication (dapsone, phenacetin, sulfonamides)
  • Nitrites
Typical presentation*
  • Neurologic symptoms from headache to coma
  • Respiratory
  • Cyanosis
  • Neurologic symptoms from headache to coma
  • Respiratory depression
  • Cyanosis
Color of the blood
  • Cherry red
  • Chocolate brown
  • Green
Pulse oximetry
  • Inaccurate
  • Inaccurate
  • Inaccurate
Arterial blood gas
  • PaO2 normal
  • Carboxyhemoglobin is detected on most machines used in the United States
  • PaO2 normal
  • Methemoglobin is detected on most machines used in the United States
  • PaO2 normal
Confirmatory testing
  • Co-oximetry using arterial blood (in stable patients, venous samples are accurate)
  • Blood gas (arterial or venous)
  • Requires specialized laboratory testing (spectrophotometry or gas chromatography)
Management
  • High-flow or hyperbaric oxygen
  • Methylene blue (MB) or ascorbic acid
  • Supportive (no antidote)
  • Exchange transfusion in severe cases
  • Lack of response to MB
This table is intended as a quick reference to compare and contrast these three conditions. Some co-oximeters cannot distinguish between methemoglobin and sulfhemoglobin because of their similar absorption peaks, and they may falsely report sulfhemoglobin as methemoglobin. Discussion with laboratory personnel is advised. Refer to UpToDate topics on each of these conditions for details of evaluation and management.

CO: carbon monoxide; PaO2: arterial partial pressure of oxygen; MB: methylene blue; G6PD: glucose-6-phosphate dehydrogenase.

* Severity of symptoms depends on the magnitude of the intoxication and the rapidity with which it develops. Symptoms may range from mild and nonspecific to life-threatening.

¶ MB is preferred; however, it should not be used in individuals with G6PD deficiency or those taking a serotonergic medication or drug. Refer to UpToDate for details of indications and dosing.
Graphic 127512 Version 4.0